TRKA is overexpressed in various cancers including pancreas, breast, lung, glioblastoma, lymphoid, oral squamous cell carcinoma, and adenoid cystic carcinoma and confers drug resistance and poor prognosis.51, 52. Here, NTRK1 is linked to cancer.